Prostate News Archive
20-Jan-2007
Vitamin pill for prostate cancer (BBC News)
Scientists develop a vitamin D pill in efforts to extend the life of patients with advanced prostate cancer. Dendreon Shares Rise on Good News for Prostate Cancer Drug (SeekingAlpha via Yahoo! Finance)
Centient Biotech Investor submits: On Tuesday, January 16, Dendreon announced the FDA has accepted its BLA for Provenge , and granted it priority review status. Provenge is an investigational active cellular immunotherapy [ACI ] for the treatment of asymptomatic, androgen-independent, or hormone-refractory prostate cancer [AIPC ]. Model identifies low-risk prostate cancer (Reuters via Yahoo! News)
An updated prognostic model can accurately identify prostate cancers that are unlikely to spread and do not require aggressive treatment, Dutch researchers report in The Journal of Urology. Sunshine Pill For Prostate Cancer In 2009 (Science Daily)
A drug based on vitamin D and is given to patients in the advanced stages of prostate cancer along with chemotherapy drugs could be availiable by 2009. Vitamin D from sunlight improves the prognosis of certain cancers, but taking natural levels of the vitamin has no effect. Novacea, the company that makes Asentar, produced a novel formulation that reproduces the healing effect without the ...
Back to Prostate News Archive
